MedTrace Logo

Monocyte Chemoattractant Protein-1 2518A/G Polymorphism

NCT02077127 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1043

Last updated 2014-03-05

No results posted yet for this study

Summary

The pathogenesis of proliferative diabetic retinopathy (PDR) remains poorly understood. Recent studies have implicated that monocyte chemoattractant protein-1 (MCP-1) is associated with diabetic microvascular or macrovascular complications. However, the relationship between SNP polymorphism c.2518A/G in the MCP-1 gene with diabetic retinopathy remains controversial. In the present study, we evaluated the association of a single nucleotide polymorphism (SNP) in the MCP-1 gene with diabetic retinopathy (DR) and diabetic macular edema (DME) in Chinese population from Southern China with type 2 diabetes.

Conditions

Sponsors & Collaborators

  • Harbin Medical University

    lead OTHER

Principal Investigators

  • Ping Liu, Doctor · First Affiliated Hospital of Harbin Medical University

Eligibility

Min Age
41 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-02-28
Completion
2013-04-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02077127 on ClinicalTrials.gov